BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34660693)

  • 1. Development and Verification of an Immune-Related Gene Pairs Prognostic Signature in Hepatocellular Carcinoma.
    Feng X; Mu S; Ma Y; Wang W
    Front Mol Biosci; 2021; 8():715728. PubMed ID: 34660693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A signature of 18 immune-related gene pairs to predict the prognosis of pancreatic cancer patients.
    Bu F; Nie H; Zhu X; Wu T; Lin K; Zhao J; Huang J
    Immun Inflamm Dis; 2020 Dec; 8(4):713-726. PubMed ID: 33128857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A signature of immune-related gene pairs (IRGPs) for risk stratification and prognosis of oral cancer patients.
    Yu Y; Tian J; Hou Y; Zhang X; Li L; Cong P; Ji L; Wang X
    World J Surg Oncol; 2022 Jul; 20(1):227. PubMed ID: 35804390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and Validation of Immune-Related Gene Prognostic Signature for Hepatocellular Carcinoma.
    Chen W; Ou M; Tang D; Dai Y; Du W
    J Immunol Res; 2020; 2020():5494858. PubMed ID: 32211443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of a Five-immune Gene Pair Signature in Endometrial Carcinoma.
    Li N; Yu K; Lin Z; Zeng D
    Comb Chem High Throughput Screen; 2021; 24(2):233-245. PubMed ID: 32729416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and Verification of an Immune-Related Gene Pairs Signature for Predicting Prognosis in Head and Neck Squamous Cell Carcinoma.
    He J; Fang X; Han M
    Front Genet; 2021; 12():654657. PubMed ID: 34108990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Immune-Related Gene Pairs Signature for Predicting Survival in Glioblastoma.
    Wang S; Xu X
    Front Oncol; 2021; 11():564960. PubMed ID: 33859933
    [No Abstract]   [Full Text] [Related]  

  • 8. An Immune-Related Gene Pairs Signature Predicts Prognosis and Immune Heterogeneity in Glioblastoma.
    Zhang N; Ge M; Jiang T; Peng X; Sun H; Qi X; Zou Z; Li D
    Front Oncol; 2021; 11():592211. PubMed ID: 33928021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of an Individualized Immune Prognostic Signature for Recurrent Prostate Cancer.
    Jin Y; Wang L; Lou H; Song C; He X; Ding M
    Comb Chem High Throughput Screen; 2021; 24(1):98-108. PubMed ID: 32593277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of an immune-related gene pairs signature in colorectal cancer.
    Wu J; Zhao Y; Zhang J; Wu Q; Wang W
    Oncoimmunology; 2019; 8(7):1596715. PubMed ID: 31143520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Inflammatory Response-Related Gene Signature Can Impact the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma.
    Lin Z; Xu Q; Miao D; Yu F
    Front Oncol; 2021; 11():644416. PubMed ID: 33828988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A signature of 17 immune-related gene pairs predicts prognosis and immune status in HNSCC patients.
    Jiang P; Li Y; Xu Z; He S
    Transl Oncol; 2021 Jan; 14(1):100924. PubMed ID: 33221687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of immune gene pair-based signature predictive of prognosis and immunotherapy in esophageal cancer.
    Cao K; Ma T; Ling X; Liu M; Jiang X; Ma K; Zhu J; Ma J
    Ann Transl Med; 2021 Oct; 9(20):1591. PubMed ID: 34790797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
    Zhang F; Liu Y; Yang Y; Yang K
    BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Survival Outcome in Lower-Grade Glioma Using a Prognostic Signature with 33 Immune-Related Gene Pairs.
    Chen S; Sun Y; Zhu X; Mo Z
    Int J Gen Med; 2021; 14():8149-8160. PubMed ID: 34803397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an immune-related gene pairs signature for predicting clinical outcome in lung adenocarcinoma.
    Wu C; Hu Q; Ma D
    Sci Rep; 2021 Feb; 11(1):3611. PubMed ID: 33574499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological perspective on the malignant progression of renal clear cell carcinoma.
    Liu J; Zhang W; Lin K; Ma W; Li W; Yao X
    Ann Transl Med; 2021 Oct; 9(20):1544. PubMed ID: 34790750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
    Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
    PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.
    Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q
    Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel tumor doubling time-related immune gene signature for prognosis prediction in hepatocellular carcinoma.
    Zhang G; Su L; Lv X; Yang Q
    Cancer Cell Int; 2021 Oct; 21(1):522. PubMed ID: 34627241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.